Skip to main content
Premium Trial:

Request an Annual Quote

Michael Young

Premium
Expressed RNAi-drug developer Nucleonics has appointed Michael Young as its chief medical officer.
 
Young joins Nucleonics from MDY-Associates, a strategic and technical consulting group where he served as president and managing consultant. Before this, he held a number of positions in the pharmaceutical industry including corporate director of worldwide regulatory and clinical development at Procter & Gamble. He holds a PhD in chemistry from the University of Wales and an MD from the Welsh School of Medicine.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.